Loading...
Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population
OBJECTIVE: Pivotal trial have shown that patients with multiple sclerosis (MS) receiving ocrelizumab had better outcomes. However, data on ocrelizumab in clinical practice are limited. The aim of this study was to evaluate the preliminary safety profile and effectiveness of ocrelizumab treatment for...
Na minha lista:
| Udgivet i: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7886031/ https://ncbi.nlm.nih.gov/pubmed/33369288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51282 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|